Randomized, Double-blind, Placebo-controlled Trial on the Effectiveness and Safety of Dapagliflozin for Blood Glucose Control During Glucocorticoid Treatment for Acute Exacerbation COPD
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin
- Indications Hyperglycaemia
- Focus Adverse reactions; Therapeutic Use
- 09 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 May 2017.
- 09 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Apr 2016 Planned End Date changed from 1 Apr 2016 to 1 Jan 2017.